Cancer
| 4 min read
A well-chosen CDx development partner can streamline drug development, reduce delays, and pave the way for successful regulatory approval and market entry.
| 4 min read
Big-ticket licensing, FDA shake-ups, and Alzheimer’s data led the news this week.
| 8 min read
By starting with T cells from healthy donors, Allogene is manufacturing off-the-shelf CAR T cell therapies that patients don’t have to wait for.
| 4 min read
Metabolic conditioning is emerging as a powerful strategy to enhance the potency, persistence, and manufacturability of next-generation cell therapies, providing new hope for hard to treat cancers.
| 4 min read
Another death linked to Sarepta’s gene therapy, a promising glioblastoma trial, a rejection for Replimune, and more led the news this week.
| 2 min read
By focusing on chemistry rather than biology alone, Actithera is aiming to elevate radiopharmaceuticals from niche applications to standard-of-care contenders.
| 4 min read
Data-led engineering and platform strategies are transforming T cell engagers into scalable, clinically viable cancer therapies.
| 4 min read
Explore the link between GLP-1 drugs and cancer. A new study reveals these therapies may reduce the risk of obesity-related cancers, similar to bariatric surgery.
| 4 min read
Multiomic approaches are advancing cancer research by delivering deeper insights and enabling more precise diagnostics and therapies.
| 4 min read
Learn about the Teal Wand™, an FDA-approved at-home HPV test from Teal Health. This self-collection test is expanding access to cervical cancer screening.
| 5 min read
From new biomarkers to smarter clinical trials, AI is transforming how cancer drugs are developed and how patients are diagnosed and treated.
| 2 min read
Early detection test to be developed in collaboration with the Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection biobank
